Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/5/08 → 07/29/10 |
Funding
- Merck and Company: $4,004.27
Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery
- Bilfinger, Thomas (CoPI)
- McLarty, Allison J. (CoPI)
- Rosengart, Todd (PI)
- Seifert, Frank (CoPI)
Project: Research